180 related articles for article (PubMed ID: 37161431)
1. Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study.
Hui B; Wang X; Wang X; Qiao B; Duan J; Shang R; Yang W; Wang J; Chen K; Yang F; Jiang T; Lei J
Int J Surg; 2023 Aug; 109(8):2286-2292. PubMed ID: 37161431
[TBL] [Abstract][Full Text] [Related]
2. [Experience of Thoracotomy and Robot-assisted Bronchial Sleeve Resection
after Neoadjuvant Chemoimmunotherapy for Local Advanced Central Lung Cancer].
Liu X; Sun T; Hong T; Yuan Y; Zhang H
Zhongguo Fei Ai Za Zhi; 2022 Feb; 25(2):71-77. PubMed ID: 35224959
[TBL] [Abstract][Full Text] [Related]
3. Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
Ji W; Jiang Y; Li Y; Mao W; Teng L
Neoplasma; 2024 Feb; 71(1):88-97. PubMed ID: 38506033
[TBL] [Abstract][Full Text] [Related]
4. A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer.
Zhang B; Xiao H; Pu X; Zhou C; Yang D; Li X; Wang W; Xiao Q
Cancer Med; 2023 Jan; 12(1):274-286. PubMed ID: 35621048
[TBL] [Abstract][Full Text] [Related]
5. [Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC].
Wang H; Han Y
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):822-832. PubMed ID: 38061884
[TBL] [Abstract][Full Text] [Related]
6. Surgical perspective in neoadjuvant chemoimmunotherapy for stage II-III non-small cell lung cancer.
Hong T; Sun T; Zhang M; Liu X; Yuan Y; Dolo PR; Chen B; Zhang H
Thorac Cancer; 2021 Oct; 12(20):2796-2802. PubMed ID: 34463034
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with
Chemotherapy in Resectable Non-small Cell Lung Cancer].
Zhou S; Hao X; Yu D; Liu S; Cao X; Su C; Song X; Xiao N; Li Y; Yang W; Zhao D; Wang J; Liu Z; Xu S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):420-425. PubMed ID: 34024062
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy does not increase postoperative morbidity of sleeve lobectomy in locally advanced non-small cell lung cancer.
Li X; Li Q; Yang F; Gao E; Lin L; Li Y; Song X; Duan L
J Thorac Cardiovasc Surg; 2023 Oct; 166(4):1234-1244.e13. PubMed ID: 36965521
[TBL] [Abstract][Full Text] [Related]
9. Perioperative Outcomes of Video-Assisted Thoracoscopic Surgery Versus Open Thoracotomy After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC.
Zhang B; Xiao Q; Xiao H; Wu J; Yang D; Tang J; Li X; Wu Z; Zhou Y; Wang W
Front Oncol; 2022; 12():858189. PubMed ID: 35712494
[TBL] [Abstract][Full Text] [Related]
10. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoimmunotherapy confers survival advantage for patients undergoing sleeve lobectomy.
Chen T; Wen J; He Y; Zhong Y; Deng J; Chen Q; She Y; Jiang L; Xie D; Zhao D; Chen C
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38539042
[TBL] [Abstract][Full Text] [Related]
12. Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
Bott MJ; Yang SC; Park BJ; Adusumilli PS; Rusch VW; Isbell JM; Downey RJ; Brahmer JR; Battafarano R; Bush E; Chaft J; Forde PM; Jones DR; Broderick SR
J Thorac Cardiovasc Surg; 2019 Jul; 158(1):269-276. PubMed ID: 30718052
[TBL] [Abstract][Full Text] [Related]
13. The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study.
Liu W; Ren S; Yang L; Xiao Y; Zeng C; Chen C; Wu F; Hu Y
Int J Surg; 2023 Nov; 109(11):3519-3526. PubMed ID: 37578441
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
[TBL] [Abstract][Full Text] [Related]
15. [Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].
Xie MR; Zhang X; Lin P; Chen JX; Ling YB; Fu JH; Rong TH; Zeng CG; Huang ZF
Ai Zheng; 2009 Aug; 28(8):868-71. PubMed ID: 19664335
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer.
Bao Y; Jiang C; Wan Z; Wang Y; Zhong Y; Deng J; She Y; Jiang L; Hu X; Zhu Y; Yu B; Chen C
Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35416960
[TBL] [Abstract][Full Text] [Related]
17. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer.
Deng H; Liu J; Cai X; Chen J; Rocco G; Petersen RH; Brunelli A; Ng CSH; D'Amico TA; Liang W; He J
Ann Surg; 2022 Mar; 275(3):e600-e602. PubMed ID: 34596079
[TBL] [Abstract][Full Text] [Related]
18. Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
Sun C; Liu Y; Zhang P; Wang X; Xu Y; Lin X; Ma X; Guo Y; Qiu S; Shao G; Yang Z; Ma K
J Cancer Res Clin Oncol; 2023 Feb; 149(2):819-831. PubMed ID: 35192053
[TBL] [Abstract][Full Text] [Related]
19. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
[TBL] [Abstract][Full Text] [Related]
20. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]